Skip to content

A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)

A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI) - A Prospective Observational Study on the Establishment of a Novel Method for Assessing Steatotic Liver Disease Using Magnetic Resonance Imaging (MRI)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056968
Enrollment
12
Registered
2025-02-07
Start date
2025-02-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Steatotic Liver Disease

Interventions

None listed

Sponsors

University of Tsukuba Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who have been identified with steatotic liver or liver dysfunction through blood tests or imaging studies in general medical examinations or health check-ups within one year prior to study enrollment.

Exclusion criteria

Exclusion criteria: 1. Individuals with a history or treatment history of liver diseases other than steatotic liver. 2. Individuals with an average daily pure ethanol intake of 30 g or more for men and 20 g or more for women. 3. Individuals who cannot undergo MRI due to the presence of metal implants in the body, claustrophobia, or other reasons. 4. Individuals who are unable to hold their breath for approximately 15 seconds. 5. Individuals with dementia or psychiatric disorders which make it difficult to understand the study. 6. Individuals deemed unsuitable by the principal investigator or the attending physician for other reasons.

Design outcomes

Primary

MeasureTime frame
The correlation between whole-liver MRI proton density fat fraction (PDFF) values and PDFF values based on region of interest (ROI) set for each liver segment.

Countries

Japan

Contacts

Public ContactTakaaki Matsuda

University of Tsukuba Hospital Department of Endocrinology and Metabolism

matsuda.takaaki.dd@ms.hosp.tsukuba.ac.jp0298533053

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026